
zzso breast cancer is considered an unique clinical entity with its own specific zzso zzso Several recently published large studies have shown that overall survival of zzso zzso carriers having breast cancer is similar to sporadic breast cancer zzso It was also suggested that better response to chemotherapy is one of the most important factors that improves the clinical outcome of breast zzso with zzso zzso zzso in zzso zzso zzso zzso Online and zzso are zzso zzso tools that estimate the survival benefit of zzso chemotherapy in primary breast cancer zzso These tools have been extensively validated in different zzso however, the accuracy of the predictions made by zzso Online and zzso among zzso zzso carriers has not yet been zzso In this study we have found, that predictions of overall and breast zzso survival obtained from zzso Online and zzso were significantly lower than the observed survival percentages in the study population zzso difference for 10-year overall zzso zzso P zzso zzso zzso zzso zzso P zzso zzso zzso Thus this study suggests that zzso Online and zzso should be used with caution in this group of zzso Further updating of zzso therapy benefit calculation tools by inclusion of the information about inherited genetic zzso should be considered to improve the performance of the zzso programs among zzso breast cancer zzso 

